Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-25, Stock:ABBV, The news for the past five days is as follows:
2019-01-17: NEWS1: 1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet).NEWS2: 1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet).NEWS3: Banks Keep Stocks Moving Higher.NEWS4: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS5: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS6: Trending: Investors Turn to Dividend Aristocrats Amid Market Volatility.NEWS7: 3 Healthcare Stocks That Will Keep Your Portfolio Healthy.NEWS8: 3 Healthcare Stocks That Will Keep Your Portfolio Healthy.
2019-01-18: NEWS1: AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study.NEWS2: AbbVie's cancer drug fails to meet main goal in late-stage study.NEWS3: AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer.NEWS4: These 3 Biotech Stocks Appear Poised To Beat Fourth-Quarter Forecasts.NEWS5: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS6: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS7: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS8: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS9: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS10: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS11: Pacira's Study on Exparel Label Expansion Meets Endpoints.NEWS12: Pacira's Study on Exparel Label Expansion Meets Endpoints.NEWS13: Are you a Tortoise or a Hare Investor?.NEWS14: Are you a Tortoise or a Hare Investor?.NEWS15: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS16: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS17: Are you a Tortoise or a Hare Investor?.NEWS18: Pacira's Study on Exparel Label Expansion Meets Endpoints.
2019-01-22: NEWS1: 5 Amazing Earnings Charts.NEWS2: 5 Amazing Earnings Charts.NEWS3: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS4: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS5: 5 Amazing Earnings Charts.NEWS6: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS7: Bet on These 5 Low Leverage Stocks to Secure Returns.NEWS8: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS9: Better Buy: Pfizer vs. AbbVie.
2019-01-23: NEWS1: Top Research Reports for Amazon, Verizon & AbbVie.NEWS2: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS3: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS4: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS5: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS6: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.
2019-01-24: NEWS1: Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?.NEWS2: Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?.NEWS3: Notable Thursday Option Activity: SEAS, ABBV, TWLO.NEWS4: Notable Thursday Option Activity: SEAS, ABBV, TWLO.NEWS5: Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?.NEWS6: Pre-Market Earnings Report for January 25, 2019 :  ABBV, NEE, CL, APD, ERIC, DHI, LEA, HRC, IBKC, NEP, ABCB, ESXB.NEWS7: Pre-Market Earnings Report for January 25, 2019 :  ABBV, NEE, CL, APD, ERIC, DHI, LEA, HRC, IBKC, NEP, ABCB, ESXB.NEWS8: What's Behind the Biotech ETF Rally to Start 2019?.NEWS9: What's Behind the Biotech ETF Rally to Start 2019?.NEWS10: Q4 Earnings Preview For AbbVie.NEWS11: Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie.NEWS12: Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie.NEWS13: The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb.NEWS14: The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb.NEWS15: Healthcare ETFs in Focus Ahead of Q4 Earnings.NEWS16: Healthcare ETFs in Focus Ahead of Q4 Earnings.NEWS17: Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?.NEWS18: Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?.NEWS19: What's Behind the Biotech ETF Rally to Start 2019?.NEWS20: Is a Surprise Coming for AbbVie (ABBV) This Earnings Season?.NEWS21: Is a Surprise Coming for AbbVie (ABBV) This Earnings Season?.NEWS22: iShares U.S. Healthcare ETF Experiences Big Inflow.NEWS23: iShares U.S. Healthcare ETF Experiences Big Inflow.NEWS24: Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?.NEWS25: Healthcare ETFs in Focus Ahead of Q4 Earnings.NEWS26: The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb.NEWS27: Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie.NEWS28: Is a Surprise Coming for AbbVie (ABBV) This Earnings Season?.NEWS29: 3 Things to Expect in AbbVie's Q4 Earnings Update.NEWS30: 3 Things to Expect in AbbVie's Q4 Earnings Update.NEWS31: 3 Things to Expect in AbbVie&apos;s Q4 Earnings Update.NEWS32: AbbVie Falls 3%.

Answer: Decrease